107 related articles for article (PubMed ID: 34582656)
1. The Effect of a Patient Navigator on Treatment Abandonment and Follow-up for High Grade Osteosarcoma Patients in the Philippine General Hospital.
Gaston CL; Taleon K; Barsales K; Dimayuga C; Estanislao J; Fajardo P; Quintos A; Rubio D; Wang E; Alcasabas AP
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2873-2877. PubMed ID: 34582656
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
3. Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study.
Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Kimpo M; Dhamne C; Blair S; Lam C; Photia A; Rujkijyanont P; Traivaree C; Pairojboriboon S; Rodriguez-Galindo C;
Pediatr Blood Cancer; 2022 Apr; 69(4):e29556. PubMed ID: 35038209
[TBL] [Abstract][Full Text] [Related]
4. AMAFRICA, a patient-navigator program for accompanying lymphoma patients during chemotherapy in Ivory Coast: a prospective randomized study.
Koffi KG; Silué DA; Laurent C; Boidy K; Koui S; Compaci G; Adeba ZH; Kamara I; Botty RP; Bognini AS; Sanogo I; Despas F; Laurent G
BMC Cancer; 2019 Dec; 19(1):1247. PubMed ID: 31870438
[TBL] [Abstract][Full Text] [Related]
5. Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children's Cancer Group.
Cai J; Yu J; Zhu X; Hu S; Zhu Y; Jiang H; Li C; Fang Y; Liang C; Ju X; Tian X; Zhai X; Hao J; Hu Q; Wang N; Jiang H; Sun L; Li CK; Pan K; Yang M; Shen S; Cheng C; Ribeiro RC; Pui CH; Tang J;
Arch Dis Child; 2019 Jun; 104(6):522-529. PubMed ID: 30705079
[TBL] [Abstract][Full Text] [Related]
6. Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.
Friedrich P; Ortiz R; Strait K; Fuentes S; Gamboa Y; Arambú I; Ah-Chu-Sanchez M; London W; Rodríguez-Galindo C; Antillón-Klussmann F; Báez F;
Cancer; 2013 Feb; 119(4):871-9. PubMed ID: 22972687
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Application of Precision Genomic Medicine Detecting Gene Variation in Patients with Multifocal Osteosarcoma.
Zhang HQ; Li MH; Gao P; Lan PH; Fan B; Xiao X; Lu YJ; Chen GJ; Wang Z
Orthop Surg; 2016 May; 8(2):129-38. PubMed ID: 27384721
[TBL] [Abstract][Full Text] [Related]
8. Patient Navigation to Enhance Access to Care for Underserved Patients with a Suspicion or Diagnosis of Cancer.
Chavarri-Guerra Y; Soto-Perez-de-Celis E; Ramos-López W; San Miguel de Majors SL; Sanchez-Gonzalez J; Ahumada-Tamayo S; Viramontes-Aguilar L; Sanchez-Gutierrez O; Davila-Davila B; Rojo-Castillo P; Perez-Montessoro V; Bukowski A; Goss PE
Oncologist; 2019 Sep; 24(9):1195-1200. PubMed ID: 30498134
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
[TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centers.
Bouaoud J; Beinse G; Epaillard N; Amor-Sehlil M; Bidault F; Brocheriou I; Hervé G; Spano JP; Janot F; Boudou-Rouquette P; Benassarou M; Schouman T; Goudot P; Malouf G; Goldwasser F; Bertolus C
Oral Oncol; 2019 Aug; 95():79-86. PubMed ID: 31345398
[TBL] [Abstract][Full Text] [Related]
11. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Yu W; Tang L; Lin F; Yao Y; Shen Z
Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
Boye K; Del Prever AB; Eriksson M; Saeter G; Tienghi A; Lindholm P; Fagioli F; Skjeldal S; Ferrari S; Hall KS
Pediatr Blood Cancer; 2014 May; 61(5):840-5. PubMed ID: 24254749
[TBL] [Abstract][Full Text] [Related]
13. Head and neck osteosarcoma at the University of Washington.
Oda D; Bavisotto LM; Schmidt RA; McNutt M; Bruckner JD; Conrad EU; Weymuller EA
Head Neck; 1997 Sep; 19(6):513-23. PubMed ID: 9278760
[TBL] [Abstract][Full Text] [Related]
14. Improvement in High-Grade Osteosarcoma Survival: Results from 202 Patients Treated at a Single Institution in Taiwan.
Hung GY; Yen HJ; Yen CC; Wu PK; Chen CF; Chen PC; Wu HH; Chiou HJ; Chen WM
Medicine (Baltimore); 2016 Apr; 95(15):e3420. PubMed ID: 27082623
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center.
Bajpai J; Chandrasekharan A; Simha V; Talreja V; Karpe A; Pandey N; Singh A; Rekhi B; Vora T; Ghosh J; Banavali S; Gupta S
J Glob Oncol; 2018 Sep; 4():1-10. PubMed ID: 30241240
[TBL] [Abstract][Full Text] [Related]
16. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
[TBL] [Abstract][Full Text] [Related]
17. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Xu M; Xu S; Yu X
World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy for osteosarcoma].
Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.
Arpaci F; Ataergin S; Ozet A; Erler K; Basbozkurt M; Ozcan A; Komurcu S; Ozturk B; Celasun B; Kilic S; Kuzhan O
Cancer; 2005 Sep; 104(5):1058-65. PubMed ID: 15999369
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of increased angiogenesis in osteosarcoma.
Kreuter M; Bieker R; Bielack SS; Auras T; Buerger H; Gosheger G; Jurgens H; Berdel WE; Mesters RM
Clin Cancer Res; 2004 Dec; 10(24):8531-7. PubMed ID: 15623635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
